Effect of typical and atypical neuroleptics on the behavioural consequences of activation by muscimol of mesolimbic and nigro-striatal dopaminergic pathways in the rat
- 34 Downloads
Direct injections of muscimol into the ventral tegmental area (VTA) or substantia nigra zona reticulata (SNR) have been used to selectively stimulate the mesolimbic and nigro-striatal dopamine pathways respectively. Such injections induced locomotor activity, rearing, sniffing and in some animals an intermittent grooming response. These responses were rapid in onset, dose-related and relatively short lasting (<40 min). Selective increases in dopamine turnover were seen in the nucleus accumbens and in the striatum following VTA and SNR injections of muscimol (100 ng) respectively. Haloperidol inhibited the behavioural consequences of VTA and SNR injections of muscimol with similar potency (ED50s 0.01–0.03 mg/kg IP), and fluphenazine did likewise (ED50s 0.05–0.16 mg/kg IP). However, thioridazine (ED50s VTA: 1.45–2.04 mg/kg IP, SNR 8.50–9.20 mg/kg IP) and in particular clozapine (ED50s VTA: 0.24–0.58 mg/kg IP, SNR: 6.10–9.70 mg/kg IP) were more potent at inhibiting the locomotor activity and sniffing responses due to VTA rather than SNR administered muscimol. Since dopamine D2 antagonists are believed to exert their anti-psychotic effects via an action on mesolimbic dopaminergic systems, and their ability to induce extrapyramidal side effects (EPS) is thought to be due to an action on nigro-striatal dopamine systems, these results suggest that the behavioural models described can be used to predict efficacy and side-effect liability of potential neuroleptic drugs.
Key wordsMesolimbic Nigro-striatal Atypical neuroleptics Typical neuroleptics Muscimol Behaviour
Unable to display preview. Download preview PDF.
- Cooper SJ, Dourish CT (1990) An introduction to the concept of stereotypy and a historical perspective on the role of brain dopamine. In: Cooper SJ, Dourish CT (eds) Neurobiology of stereotyped behaviour. Clarendon Press, Oxford, pp 1–24Google Scholar
- Fallon JE, Loughlin SE (1985) In: Paxinos G (ed) The rat nervous system, vol 1. Academic Press, Sydney, pp 353–374Google Scholar
- Iversen SD (1986) Animal models of schizophrenia. In: Bradley PB, Hirsch SR (eds) The psychopharmacology and treatment of schizophrenia. Oxford University Press, Oxford, pp 71–102Google Scholar
- Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113Google Scholar
- Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia. Schizophren Bull 2:19–76Google Scholar
- Paxinos G, Watson C (1982) The rat brain in stereotaxic co-ordinates. Academic Press, New YorkGoogle Scholar